Home > Healthcare > Pharmaceuticals > Finished Drug Form > Growth Hormone Market

Growth Hormone Market Trends

Report ID: GMI5042
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Growth Hormone Market Trends

Surging advancements in drug delivery systems will create lucrative opportunities for industry progress. Innovations such as wearable patches, needle-free devices, and autoinjectors have come to the forefront, which helps enhance the convenience and patient compliance of growth hormone therapies. Moreover, long-acting formulations and implantable devices are also increasingly being used that allow for extended-release and sustained delivery of growth hormone, reducing dosing frequency. These innovations improve treatment outcomes and enhance patient experiences while expanding the reach of growth hormone therapies.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Growth hormone industry was valued at over USD 3.3 billion in 2022 and will grow at more than 6% CAGR from 2023 to 2032, attributed to the rising prevalence of growth hormone deficiency globally.

The growth hormone powder segment size will reach over USD 3.9 billion by 2032, owing to its ease of storage, cost-effectiveness, and long shelf life.

North America growth hormone market amassed over 43% revenue share in 2022 on account of huge investment in R&D activities for the development of innovative growth hormone medications in the region.

Major growth hormone industry players include Novo Nordisk A/S, Novartis AG, Merck KGaA, Ipsen S.A., Pfizer Inc., Eli Lily And Company, and Anhui Anke Biotechnology (Group) Co., Ltd, among others.